# Atanu Bhattacharjee

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/atanu-bhattacharjee/

## Facts

| Field | Value |
| --- | --- |
| Citations | 3,503 |
| Field | Head and Neck Cancer Studies |
| h-index | 24 |
| i10-index | 76 |
| Last Known Institution | University of Dundee |
| OpenAlex ID | https://openalex.org/A5026978593 |
| ORCID iD | 0000-0002-5757-5513 |
| Works | 375 |

## Researcher papers

- [Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in <i>EGFR</i>-Mutated Lung Cancer](https://scholariq.org/papers/gefitinib-versus-gefitinib-plus-pemetrexed-and-carboplatin-chemotherapy-in-i/)
- [Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial](https://scholariq.org/papers/once-a-week-versus-once-every-3-weeks-cisplatin-chemoradiation-for-locally/)
- [Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study](https://scholariq.org/papers/low-dose-immunotherapy-in-head-and-neck-cancer-a-randomized-study/)
- [Isolation and Characterisation of Mesenchymal Stem Cells from Different Regions of the Human Umbilical Cord](https://scholariq.org/papers/isolation-and-characterisation-of-mesenchymal-stem-cells-from-different-regions/)
- [A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer](https://scholariq.org/papers/a-randomized-phase-3-trial-comparing-nimotuzumab-plus-cisplatin/)
- [Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial](https://scholariq.org/papers/low-cost-oral-metronomic-chemotherapy-versus-intravenous-cisplatin-in-patients/)
- [A prospective randomized phase II study comparing metronomic chemotherapy with chemotherapy (single agent cisplatin), in patients with metastatic, relapsed or inoperable squamous cell carcinoma of head and neck](https://scholariq.org/papers/a-prospective-randomized-phase-ii-study-comparing-metronomic-chemotherapy-with/)
- [Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation](https://scholariq.org/papers/results-of-phase-iii-randomized-trial-for-use-of-docetaxel-as-a-radiosensitizer/)
- [Phase I/II Study of Palliative Triple Metronomic Chemotherapy in Platinum-Refractory/Early-Failure Oral Cancer](https://scholariq.org/papers/phase-i-ii-study-of-palliative-triple-metronomic-chemotherapy-in-platinum/)
- [Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma](https://scholariq.org/papers/phase-iii-study-of-gefitinib-or-pemetrexed-with-carboplatin-in-egfr-mutated/)
- [1339P Real-world experience of dacomitinib in mEGFR Advanced NSCLC: A single centre experience](https://scholariq.org/papers/1339p-real-world-experience-of-dacomitinib-in-megfr-advanced-nsclc-a-single/)

## Researcher topics

- [Head and Neck Cancer Studies](https://scholariq.org/topics/head-and-neck-cancer-studies/)
- [Statistical Methods and Inference](https://scholariq.org/topics/statistical-methods-and-inference/)
- [Statistical Methods in Clinical Trials](https://scholariq.org/topics/statistical-methods-in-clinical-trials/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Statistical Methods and Bayesian Inference](https://scholariq.org/topics/statistical-methods-and-bayesian-inference/)

## Researcher university

- [University of Dundee](https://scholariq.org/institutions/university-of-dundee/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.